Business Description
Shin Nippon Biomedical Laboratories Ltd
ISIN : JP3379950003
Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.49 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.88 | |||||
| Debt-to-EBITDA | 3.71 | |||||
| Interest Coverage | 30.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.06 | |||||
| Beneish M-Score | -1.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.9 | |||||
| 3-Year EBITDA Growth Rate | 28 | |||||
| 3-Year EPS without NRI Growth Rate | 46.1 | |||||
| 3-Year Book Growth Rate | 17.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.39 | |||||
| 9-Day RSI | 43.81 | |||||
| 14-Day RSI | 42.32 | |||||
| 6-1 Month Momentum % | -6.63 | |||||
| 12-1 Month Momentum % | -34.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.58 | |||||
| Days Inventory | 261.27 | |||||
| Days Sales Outstanding | 64.89 | |||||
| Days Payable | 14.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.49 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| 3-Year Dividend Growth Rate | 115.4 | |||||
| Forward Dividend Yield % | 3.49 | |||||
| 5-Year Yield-on-Cost % | 3.49 | |||||
| Shareholder Yield % | -10.38 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.19 | |||||
| Operating Margin % | 14.97 | |||||
| Net Margin % | 20.61 | |||||
| FCF Margin % | -3.56 | |||||
| ROE % | 19.27 | |||||
| ROA % | 8.64 | |||||
| ROIC % | 5.6 | |||||
| ROC (Joel Greenblatt) % | 32.16 | |||||
| ROCE % | 16.75 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.96 | |||||
| PE Ratio without NRI | 10.73 | |||||
| Shiller PE Ratio | 25 | |||||
| PEG Ratio | 0.14 | |||||
| PS Ratio | 2.26 | |||||
| PB Ratio | 1.99 | |||||
| Price-to-Tangible-Book | 2.16 | |||||
| Price-to-Operating-Cash-Flow | 15.06 | |||||
| EV-to-EBIT | 10.28 | |||||
| EV-to-EBITDA | 10.28 | |||||
| EV-to-Revenue | 2.77 | |||||
| EV-to-FCF | -76.63 | |||||
| Price-to-Projected-FCF | 1.5 | |||||
| Price-to-Median-PS-Value | 1.21 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.43 | |||||
| Price-to-Graham-Number | 1.01 | |||||
| Earnings Yield (Greenblatt) % | 9.73 | |||||
| FCF Yield % | -1.58 | |||||
| Forward Rate of Return (Yacktman) % | 23.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shin Nippon Biomedical Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 26,703.998 | ||
| EPS (TTM) (円) | 132.173 | ||
| Beta | -0.52 | ||
| Volatility % | 23.04 | ||
| 14-Day RSI | 42.32 | ||
| 14-Day ATR (円) | 40.953467 | ||
| 20-Day SMA (円) | 1467.65 | ||
| 12-1 Month Momentum % | -34.37 | ||
| 52-Week Range (円) | 1397 - 2612 | ||
| Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shin Nippon Biomedical Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shin Nippon Biomedical Laboratories Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shin Nippon Biomedical Laboratories Ltd Frequently Asked Questions
What is Shin Nippon Biomedical Laboratories Ltd(TSE:2395)'s stock price today?
The current price of TSE:2395 is 円1448.00. The 52 week high of TSE:2395 is 円2612.00 and 52 week low is 円1397.00.
When is next earnings date of Shin Nippon Biomedical Laboratories Ltd(TSE:2395)?
The next earnings date of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) is .
Does Shin Nippon Biomedical Laboratories Ltd(TSE:2395) pay dividends? If so, how much?
The Dividend Yield %  of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) is 3.49% (As of Today), Highest Dividend Payout Ratio of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) was 0.37. The lowest was 0.06. And the median was 0.09. The  Forward Dividend Yield % of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) is 3.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers